Missing/wrong data?
Log in to edit
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial
scientific article published on 19 February 2020
Author/s
author: Mariusz Bidziński, Giovanni Scambia, Radosław Mądry, Nicoletta Colombo
Work details
Publication date
February 19, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.